Cancer Biopsy Market is projected to increase at a CAGR of around 18% from 2023 to 2033
The Cancer Biopsy market revenues were estimated at US$ 22.2 Bn in 2022 and is anticipated to grow at a CAGR of 18% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 131.4 Bn.The increasing elderly populace, along with the rise in...
Source: pharmiweb.com